// App-Quantinova.ai

1004 : Assessing Early Mortality in Intensively-Treated Acute Myeloid Leukemia in a Developing Country: Genetic, Laboratory Findings, and Comorbidities Add Prognostic Information

Researchers

Presenter

  • Fernanda Rodrigues Mendes

Principal Investigators

  • Wellington F Silva

  • Raphael Bandeira Melo

  • Douglas R. A. Silveira

  • Elvira Velloso

  • Vanderson Rocha

  • Eduardo M Rego

Medical Centers

  • Division of Hematology,Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo,São Paulo,巴西

  • Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology,Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo,São Paulo,Brasile

  • Instituto do Cancer de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil

  • Division of Rheumatology, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, sao paulo, Sao Paulo, Brazil

  • Division of Hematology, Hospital das Clínicas da Faculdade de Medicina (HCFMUSP), University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil

  • Instituto do Cancer de São Paulo (ICESP), University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil

  • Division of Rheumatology - Hospital das Clinicas - Medical School, University of Sao Paulo, Sao Paulo, Brazil

  • Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

  • Medical Research Laboratory on Molecular Hematology (LIM-31), University of São Paulo, Sao Paulo, Sp, Brazil

  • Medical Research Laboratory on Molecular Hematology (LIM-31), University of São Paulo, Sao Paulo, Sp, Brazil

  • Instituto Do Câncer Do Estado de São Paulo, Hospital Das Clínicas Hcfmusp, Faculdade de Medicina, Universidade de São Paulo, São Paulo/BR

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Acute renal failure

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A